Long-term use of prescription opioids for non-cancer pain and mortality: a population-based, propensity-weighted cohort study

Autor: Hurtado, I., Robles, C., García-Sempere, A., Llopis-Cardona, F., Sánchez-Sáez, F., Rodríguez-Bernal, C., Peiró, S., Sanfélix-Gimeno, G.

Publikováno v: In Public Health July 2024 232:4-13

Therapeutic management, adherence, and clinical outcomes of heart failure in Andalucía. ANDALIC Protocol.

Autor: Rodríguez-Ramallo H; Unidad de Gestión Clínica de Farmacia, Hospital Universitario Virgen del Rocío, Sevilla, España., Báez-Gutiérrez N; Unidad de Gestión Clínica de Farmacia, Hospital Universitario Virgen Macarena, Sevilla, España., Jaramillo-Ruiz D; Unidad de Gestión Clínica de Farmacia, Hospital Universitario Virgen del Rocío, Sevilla, España. Electronic address: didiana.jaramillo.ruiz.sspa@juntadeandalucia.es., Sanfélix-Gimeno G; Fundación para la Promoción de la Salud e Investigación Biomédica de la Comunidad Valenciana, Valencia, España., Villegas-Portero R; Subdirección Técnica Asesora de Gestión de la Información (STAGI) del Servicio Andaluz de Salud (SAS), Sevilla, España., Jiménez-Murillo JL; Subdirección Técnica Asesora de Gestión de la Información (STAGI) del Servicio Andaluz de Salud (SAS), Sevilla, España., Hernández-Quiles C; Unidad de Gestión Clínica de Medicina Interna, Hospital Universitario Virgen del Rocío, Sevilla, España., Santos-Ramos B; Unidad de Gestión Clínica de Farmacia, Hospital Universitario Virgen del Rocío, Sevilla, España.

Publikováno v: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria [Farm Hosp] 2024 Nov-Dec; Vol. 48 (6), pp. 294-298. Date of Electronic Publication: 2024 Apr 06.

Metadata for Data dIscoverability aNd Study rEplicability in obseRVAtional Studies (MINERVA): Lessons Learnt From the MINERVA Project in Europe.

Autor: Gini R; Agenzia Regionale di Sanità Della Toscana, Florence, Italy., Pajouheshnia R; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands.; Department of Epidemiology, RTI Health Solutions, Barcelona, Spain., Gutierrez L; Department of Epidemiology, RTI Health Solutions, Barcelona, Spain., Swertz MA; Department of Genetics, University Medical Centre Groningen, Groningen, The Netherlands., Hyde E; Department of Genetics, University Medical Centre Groningen, Groningen, The Netherlands., Sturkenboom M; Department of Datascience and Biostatistics, University Medical Centre Utrecht, Utrecht, The Netherlands., Arana A; Department of Epidemiology, RTI Health Solutions, Barcelona, Spain., Franzoni C; Department of Epidemiology, RTI Health Solutions, Barcelona, Spain., Ehrenstein V; Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark., Roberto G; Agenzia Regionale di Sanità Della Toscana, Florence, Italy., Gil M; Base de Datos Para la Investigación Farmacoepidemiológica en Atención Primaria, Agencia Española de Medicamentos y Productos Sanitarios, Madrid, Spain., Maciá MA; Base de Datos Para la Investigación Farmacoepidemiológica en Atención Primaria, Agencia Española de Medicamentos y Productos Sanitarios, Madrid, Spain., Schäfer W; Department of Clinical Epidemiology, Leibniz Institute for Prevention Research and Epidemiology, Bremen, Germany., Haug U; Department of Clinical Epidemiology, Leibniz Institute for Prevention Research and Epidemiology, Bremen, Germany.; Faculty of Human and Health Science, University of Bremen, Bremen, Germany., Thurin NH; Bordeaux PharmacoEpi, INSERM CIC-P 1401, Université de Bordeaux, Bordeaux, France., Lassalle R; Bordeaux PharmacoEpi, INSERM CIC-P 1401, Université de Bordeaux, Bordeaux, France., Droz-Perroteau C; Bordeaux PharmacoEpi, INSERM CIC-P 1401, Université de Bordeaux, Bordeaux, France., Zaccagnino S; European Society for Blood & Marrow Transplantation, Leiden, The Netherlands., Busto MP; European Society for Blood & Marrow Transplantation, Leiden, The Netherlands., Middelkoop B; European Society for Blood & Marrow Transplantation, Leiden, The Netherlands., Gembert K; Department of Epidemiology, Karolinska Institutet, Stockholm, Sweden., Sanchez-Saez F; Health Services Research & Pharmacoepidemiology Unit, Foundation for the Promotion of Health and Biomedical Research of the Valencia Region, Valencia, Spain., Rodriguez-Bernal C; Health Services Research & Pharmacoepidemiology Unit, Foundation for the Promotion of Health and Biomedical Research of the Valencia Region, Valencia, Spain., Sanfélix-Gimeno G; Health Services Research & Pharmacoepidemiology Unit, Foundation for the Promotion of Health and Biomedical Research of the Valencia Region, Valencia, Spain., Hurtado I; Health Services Research & Pharmacoepidemiology Unit, Foundation for the Promotion of Health and Biomedical Research of the Valencia Region, Valencia, Spain., Acosta MB; Spanish Working Group on Crohn's Disease and Ulcerative Colitis, Bilbao, Spain., Poblador-Plou B; EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, Zaragoza, Spain., Carmona-Pírez J; EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, Zaragoza, Spain.; Technical Advisory Subdirectorate of Information Management (STAGI), Andalusian Health Service (SAS), Seville, Spain., Gimeno-Miguel A; EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, Zaragoza, Spain., Prados-Torres A; EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, Zaragoza, Spain., Schultze A; Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK., Jansen E; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands., Herings R; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands., Kuiper J; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands., Locatelli I; University of Ljubljana, Faculty of Pharmacy, Ljubljana, Slovenia., Jazbar J; University of Ljubljana, Faculty of Pharmacy, Ljubljana, Slovenia., Žerovnik Š; University of Ljubljana, Faculty of Pharmacy, Ljubljana, Slovenia., Kos M; University of Ljubljana, Faculty of Pharmacy, Ljubljana, Slovenia., Smit S; Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia., Lind S; Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia., Metspalu A; Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia., Simou S; European Medicines Agency, Amsterdam, The Netherlands., Hedenmalm K; European Medicines Agency, Amsterdam, The Netherlands., Cochino A; European Medicines Agency, Amsterdam, The Netherlands., Alcini P; European Medicines Agency, Amsterdam, The Netherlands., Kurz X; European Medicines Agency, Amsterdam, The Netherlands., Perez-Gutthann S; Department of Epidemiology, RTI Health Solutions, Barcelona, Spain.

Publikováno v: Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2024 Aug; Vol. 33 (8), pp. e5884.

COVID-19 and pregnancy: A European study on pre- and post-infection medication use.

Autor: Hurley E; PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway., Geisler BP; PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway.; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Lupattelli A; PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway., Poblador-Plou B; EpiChron Research Group, Aragon Health Sciences Institute, Miguel Servet University Hospital, Saragossa, Spain.; Network for Research on Chronicity, Primary Care, and Health Promotion, Research Network on Health Services in Chronic Diseases, Institute of Health Carlos III, Madrid, Spain., Lassalle R; Bordeaux PharmacoEpi, Plateforme de recherche en Pharmaco-épidémiologie, Bordeaux, France., Jové J; Bordeaux PharmacoEpi, Plateforme de recherche en Pharmaco-épidémiologie, Bordeaux, France., Bernard MA; Bordeaux PharmacoEpi, Plateforme de recherche en Pharmaco-épidémiologie, Bordeaux, France., Sakr D; Bordeaux PharmacoEpi, Plateforme de recherche en Pharmaco-épidémiologie, Bordeaux, France., Sanfélix-Gimeno G; Health Services Research and Pharmacoepidemiology Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region, Valencia, Spain., Sánchez-Saez F; Health Services Research and Pharmacoepidemiology Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region, Valencia, Spain., Rodríguez-Bernal CL; Health Services Research and Pharmacoepidemiology Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region, Valencia, Spain., Sabaté M; Department of Clinical Pharmacology, Vall d`Hebron Hospital Universitari, Vall Hebron Institut de Recerca, Barcelona, Spain., Ballarín E; Department of Clinical Pharmacology, Vall d`Hebron Hospital Universitari, Vall Hebron Institut de Recerca, Barcelona, Spain., Aguilera C; Department of Clinical Pharmacology, Vall d`Hebron Hospital Universitari, Vall Hebron Institut de Recerca, Barcelona, Spain., Jordan S; Faculty of Medicine, Health and Life Science, Swansea University, Swansea, Wales, UK., Thayer D; Faculty of Medicine, Health and Life Science, Swansea University, Swansea, Wales, UK., Farr I; Faculty of Medicine, Health and Life Science, Swansea University, Swansea, Wales, UK., Ahmed S; Faculty of Medicine, Health and Life Science, Swansea University, Swansea, Wales, UK., Bartolini C; Agenzia Regionale di Sanità della Toscana, Florence, Italy., Limoncella G; Agenzia Regionale di Sanità della Toscana, Florence, Italy., Paoletti O; Agenzia Regionale di Sanità della Toscana, Florence, Italy., Gini R; Agenzia Regionale di Sanità della Toscana, Florence, Italy., Maglanoc LA; IT Department, Data Management, University of Oslo, Oslo, Norway., Dudukina E; Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark., Ehrenstein V; Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark., Alsina E; Department of Data Science and Biostatistics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands., Vaz TA; Department of Data Science and Biostatistics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands., Riera-Arnau J; Department of Clinical Pharmacology, Vall d`Hebron Hospital Universitari, Vall Hebron Institut de Recerca, Barcelona, Spain.; Department of Data Science and Biostatistics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands., Sturkenboom MCJM; Department of Data Science and Biostatistics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands., Nordeng HME; PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway. h.m.e.nordeng@farmasi.uio.no.; Department of Child Health and Development, Norwegian Institute of Public Health, Oslo, Norway. h.m.e.nordeng@farmasi.uio.no.

Publikováno v: European journal of clinical pharmacology [Eur J Clin Pharmacol] 2024 May; Vol. 80 (5), pp. 707-716. Date of Electronic Publication: 2024 Feb 12.

Author Correction: Treatment patterns and appropriateness of antipsychotic prescriptions in patients with schizophrenia.

Autor: Gamón V; Health Services Research Unit, Fundación Para el Fomento de La Investigación Sanitaria y Biomédica de la Comunidad Valenciana, FISABIO (the Valencia Foundation for the Promotion of Health and Biomedical Research), Valencia, Spain., Hurtado I; Health Services Research Unit, Fundación Para el Fomento de La Investigación Sanitaria y Biomédica de la Comunidad Valenciana, FISABIO (the Valencia Foundation for the Promotion of Health and Biomedical Research), Valencia, Spain. hurtado_isa@gva.es.; Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC, ), Valencia, Spain. hurtado_isa@gva.es., Salazar-Fraile J; Community Mental Health Centre Pere Bonfill, Valencia, Spain.; Consorcio Hospital General, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Valencia, Spain., Sanfélix-Gimeno G; Health Services Research Unit, Fundación Para el Fomento de La Investigación Sanitaria y Biomédica de la Comunidad Valenciana, FISABIO (the Valencia Foundation for the Promotion of Health and Biomedical Research), Valencia, Spain.; Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC, ), Valencia, Spain.

Publikováno v: Scientific reports [Sci Rep] 2024 Mar 01; Vol. 14 (1), pp. 5138. Date of Electronic Publication: 2024 Mar 01.